The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes.
Open accessAbstract
Psoriasis is an inflammatory skin disorder characterized by epidermal keratinocyte hyperproliferation in association with a cellular infiltrate. There is evidence that activated T cells play a role in psoriatic plaque formation. We examined the T-cell receptor beta-chain variable gene segment (V beta) use of epidermal T cells in shave biopsies of psoriatic lesions. Our results show increased expression of V beta 3 and/or V beta 13.1 messages in the CD8+, but not CD4+, T cells in the lesions of a majority of patients studied. Sequence analysis of complementarity-determining region 3 (CDR3) of these two V beta genes from the skin demonstrated monoclonality or marked oligoclonality. A second biopsy from the same or different lesions, performed 3.5-8 months later in four patients, again revealed increased V beta 3 and/or V beta 13.1 expression and clonality. Moreover, in three of the four patients, the same V beta CDR3 rearrangement was found in both biopsies, although there was no V beta CDR3 homology between patients. In two patients in which V beta 3 and/or V beta 13.1 was not increased, an increase in V beta 17 gene use and clonality was found. The clonality of V beta sequence data indicates these cells are recruited and expanded in situ. The persistence of V beta 3-and/or V beta 13.1-bearing CD8+ T cells in lesions that did not undergo resolution suggests their role as effector cells rather than as regulatory cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor.
Foster, C. A., Yokozeki, H., Rappersberger, K., Koning, F., Volc-Platzer, B., Rieger, A., Coligan, J. E., Wolff, K., & Stingl, G. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.4.997 · Cited by 182
Cited by
Psoriasis pathogenesis and the development of novel targeted immune therapies
Hawkes, J. E., Chan, T. C., & Krueger, J. G. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.004 · Cited by 972
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 606
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
The immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 600
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5857 · Cited by 597
Ma, H.-L., Liang, S., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M., Gill, D., Dunussi-Joannopoulos, K., Collins, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33263 · Cited by 544
Getting under the skin: the immunogenetics of psoriasis
Bowcock, A. M., & Krueger, J. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1689 · Cited by 484
Inflammatory Skin Diseases, T Cells, and Immune Surveillance
Robert, C., & Kupper, T. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412407 · Cited by 475
Dermal injection of immunocytes induces psoriasis.
Wrone-Smith, T., & Nickoloff, B. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118989 · Cited by 439
Immunopathogenic mechanisms in psoriasis
GUDJONSSON, J. E., JOHNSTON, A., SIGMUNDSDOTTIR, H., & VALDIMARSSON, H. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02310.x · Cited by 397
New insights of T cells in the pathogenesis of psoriasis
Cai, Y., Fleming, C., & Yan, J. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.15 · Cited by 389
Melanocyte antigen triggers autoimmunity in human psoriasis
Arakawa, A., Siewert, K., Stöhr, J., Besgen, P., Kim, S.-M., Rühl, G., Nickel, J., Vollmer, S., Thomas, P., Krebs, S., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151093 · Cited by 361
Biomimetic nanoparticles for inflammation targeting
Jin, K., Luo, Z., Zhang, B., & Pang, Z. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.12.002 · Cited by 359
Inflammation as “common soil” of the multifactorial diseases
Scrivo, R., Vasile, M., Bartosiewicz, I., & Valesini, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.12.006 · Cited by 336
Molecular Dissection of Psoriasis: Integrating Genetics and Biology
Elder, J. T., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Stuart, P. E., Tejasvi, T., Voorhees, J. J., Abecasis, G. R., & Nair, R. P. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.319 · Cited by 320
Abrams, J. R., Kelley, S. L., Hayes, E., Kikuchi, T., Brown, M. J., Kang, S., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Linsley, P. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.681 · Cited by 318
Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis
Nassif, A., Bensussan, A., Bachot, N., Bagot, M., Boumsell, L., Roujeau, J.-C., Dorothée, G., & Mami-Chouaib, F. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01622.x · Cited by 310
Lepore, M., Kalinichenko, A., Colone, A., Paleja, B., Singhal, A., Tschumi, A., Lee, B., Poidinger, M., Zolezzi, F., Quagliata, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms4866 · Cited by 308
Ozawa, M., Ferenczi, K., Kikuchi, T., Cardinale, I., Austin, L. M., Coven, T. R., Burack, L. H., & Krueger, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.711 · Cited by 298
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.
Leung, D. Y., Travers, J. B., Giorno, R., Norris, D. A., Skinner, R., Aelion, J., Kazemi, L. V., Kim, M. H., Trumble, A. E., & Kotb, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118263 · Cited by 295
Lew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 284
The pathogenesis of psoriasis: immunological facts and speculations
Bos, J. D., & De Rie, M. A. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01381-4 · Cited by 284
Jackow, C. M., Cather, J. C., Hearne, V., Asano, A. T., Musser, J. M., & Duvic, M. (1997) · Blood · doi:10.1182/blood.v89.1.32 · Cited by 270
α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis
Conrad, C., Boyman, O., Tonel, G., Tun-Kyi, A., Laggner, U., de Fougerolles, A., Kotelianski, V., Gardner, H., & Nestle, F. O. (2007) · Nature Medicine · doi:10.1038/nm1605 · Cited by 265
Injection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis
Nickoloff, B. J., & Wrone-Smith, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65109-7 · Cited by 260
Metadata
- Authors
- Chang, J. C., Smith, L. R., Froning, K. J., Schwabe, B. J., Laxer, J. A., Caralli, L. L., Kurland, H. H., Karasek, M. A., Wilkinson, D. I., & Carlo, D. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-09-27
- Volume
- 91
- Issue
- 20
- Pages
- 9282-9286
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2038226782
- Cited by
- 232
- References
- 1
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.